Pulmatrix, Inc. (PULM)
NASDAQ: PULM · Real-Time Price · USD
2.190
+0.090 (4.29%)
Sep 20, 2024, 4:00 PM EDT - Market closed

Pulmatrix Revenue

Pulmatrix had revenue of $1.55M in the quarter ending June 30, 2024, a decrease of -15.84%. This brings the company's revenue in the last twelve months to $11.39M, up 64.55% year-over-year. In the year 2023, Pulmatrix had annual revenue of $7.30M with 20.21% growth.

Revenue (ttm)
$11.39M
Revenue Growth
+64.55%
P/S Ratio
0.70
Revenue / Employee
$517,818
Employees
22
Market Cap
8.00M

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 20237.30M1.23M20.21%
Dec 31, 20226.07M902.00K17.45%
Dec 31, 20215.17M-7.47M-59.09%
Dec 31, 202012.63M4.72M59.72%
Dec 31, 20197.91M7.76M5,069.93%
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro
Dec 31, 2016 Pro Pro Pro
Dec 31, 2015 Pro Pro Pro
Dec 31, 2014 Pro Pro Pro
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
Syra Health 7.07M
NeuroMetrix 4.38M
Addex Therapeutics 1.53M
TFF Pharmaceuticals 1.20M
Mangoceuticals 866.79K
Soligenix 494.62K
Traws Pharma 226.00K
ABVC BioPharma 136.40K
Revenue Rankings